Bioequivalence Study of Budesonide/Formoterol Inhalation Powder in Healthy Participants
NCT07804303
Asthma, Bronchial Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT Number: NCT00041834
This study surveys the parents/guardians about symptoms and diagnosis of asthma in kindergarten and first-grade students in 13 schools around the city of Anchorage, Alaska. Traffic information is also measured and entered in geographical information mapping system with student's home and school locations. The study will assess whether students living in high traffic areas have greater risk of diagnosis of asthma.
Looking for future studies?
Notify MeSurvey was distributed through the schools. Parents/guardians were asked about indoor exposures such as environmental tobacco smoke, insects, mold, woodstoves, as well as demographic information about the child and housing type, income,also biologic information about parental asthma. Questions included symptoms of respiratory illness as well as wheezing and medication use. Civil engineering department measured traffic on local roadways and gathered traffic information from state and municipal sources regarding traffic on arterioles and major traffic arteries. All information was entered into geographical information system (GIS) including the closest cross-streets to the child's home and the school location. Traffic exposure variables are being developed for each child and will be added to the database on indoor exposures. A regression model will be used to determine the significance of traffic exposure in receiving a diagnosis of asthma for children five to seven years of age.
National Institute of Environmental Health Sciences (NIEHS)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07804303
Asthma, Bronchial Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT01721291
Asthma, Bronchial Diseases
London, United Kingdom
View Trial DetailsNCT05623059
Asthma, Bronchial Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT01399411
Asthma, Autoimmune Diseases
Iowa City, Illinois, United States
View Trial Details